Trials / Completed
CompletedNCT00641212
Children, Perennial Allergic Rhinitis (PAR), l-t Growth
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Long-Term Treatment With Rhinocort Aqua (Budesonide) Nasal Spray in Children With Perennial Allergic Rhinitis.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 209 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 4 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effect of Rhinocort nasal spray with placebo on growth in children with perennial allergic rhinitis over 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Budesonide | |
| DRUG | Placebo |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2003-04-01
- Completion
- 2003-04-01
- First posted
- 2008-03-24
- Last updated
- 2009-03-25
Source: ClinicalTrials.gov record NCT00641212. Inclusion in this directory is not an endorsement.